<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 08 May 2019 07:32:56 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>MabVax Therapeutics (MBVX) Agrees to Sell Antibody Assets to BioNTech SE</title>
   <link>http://www.streetinsider.com/Corporate+News/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</guid>
   <pubDate>Wed, 08 May 2019 07:32:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics (MBVX) Agrees to Sell Antibody Assets to BioNTech SE</title>
   <link>http://www.streetinsider.com/Management+Comments/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</guid>
   <pubDate>Wed, 08 May 2019 07:32:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics (MBVX) Agrees to Sell Antibody Assets to BioNTech SE</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/MabVax+Therapeutics+%28MBVX%29+Agrees+to+Sell+Antibody+Assets+to+BioNTech+SE/15468844.html</guid>
   <pubDate>Wed, 08 May 2019 07:32:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioNTech+Acquires+MabVax+Therapeutics%E2%80%99+Antibody+Assets+to+Expand+Portfolio/15468566.html</guid>
   <pubDate>Wed, 08 May 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08310191</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.29463264</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33663683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.35146065</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>Form  8-K        MABVAX THERAPEUTICS HOLD  For: Mar 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Mar+21/15295083.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Mar+21/15295083.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Mar+21/15295083.html</guid>
   <pubDate>Mon, 25 Mar 2019 16:50:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>Form  8-K        MABVAX THERAPEUTICS HOLD  For: Jan 03</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Jan+03/14974801.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Jan+03/14974801.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Jan+03/14974801.html</guid>
   <pubDate>Fri, 04 Jan 2019 08:13:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics and Oncotelic Enter into Merger Discussions</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</guid>
   <pubDate>Fri, 04 Jan 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics and Oncotelic Enter into Merger Discussions</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</guid>
   <pubDate>Fri, 04 Jan 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics and Oncotelic Enter into Merger Discussions</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+and+Oncotelic+Enter+into+Merger+Discussions/14974717.html</guid>
   <pubDate>Fri, 04 Jan 2019 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</guid>
   <pubDate>Thu, 13 Dec 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14939678</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</guid>
   <pubDate>Thu, 13 Dec 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14939678</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</guid>
   <pubDate>Thu, 13 Dec 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14939678</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Engages+Objective+Capital+as+Advisor+for+Exploring+Asset+Sales/14919353.html</guid>
   <pubDate>Thu, 13 Dec 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14939678</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</guid>
   <pubDate>Wed, 28 Nov 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</guid>
   <pubDate>Wed, 28 Nov 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MabVax+Therapeutics+Holdings%2C+Inc.+Announces+%241.0+Million+Equity+Purchase+Agreement/14868622.html</guid>
   <pubDate>Wed, 28 Nov 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08498496</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.32727947</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>Form  S-1        MABVAX THERAPEUTICS HOLD             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++MABVAX+THERAPEUTICS+HOLD+++++++++++++/14852589.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++MABVAX+THERAPEUTICS+HOLD+++++++++++++/14852589.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++MABVAX+THERAPEUTICS+HOLD+++++++++++++/14852589.html</guid>
   <pubDate>Tue, 20 Nov 2018 17:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>Form  8-K        MABVAX THERAPEUTICS HOLD  For: Nov 19</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Nov+19/14852494.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Nov+19/14852494.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Nov+19/14852494.html</guid>
   <pubDate>Tue, 20 Nov 2018 17:06:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
  <item>
   <title>Form  10-Q       MABVAX THERAPEUTICS HOLD  For: Sep 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Sep+30/14824045.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Sep+30/14824045.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MABVAX+THERAPEUTICS+HOLD++For%3A+Sep+30/14824045.html</guid>
   <pubDate>Tue, 13 Nov 2018 17:32:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MBVX</category>
   	  </item>
 </channel>
</rss>
